MARKET

WGS

WGS

GeneDx Holdings Corp
NASDAQ
91.44
-3.34
-3.52%
Pre Market: 92.20 +0.76 +0.83% 08:02 02/12 EST
OPEN
95.19
PREV CLOSE
94.78
HIGH
97.30
LOW
90.60
VOLUME
107
TURNOVER
0
52 WEEK HIGH
170.87
52 WEEK LOW
55.17
MARKET CAP
2.64B
P/E (TTM)
1477.22
1D
5D
1M
3M
1Y
5Y
1D
*TIME Names GeneDx CEO Katherine Stueland To The 2026 TIME100 Health List Of The World's Most Influential Leaders In Health >WGS
Dow Jones · 1d ago
First Week of March 27th Options Trading For GeneDx Holdings (WGS)
NASDAQ · 2d ago
Forecasting The Future: 4 Analyst Projections For GeneDx Holdings
Benzinga · 3d ago
GeneDx Holdings Price Target Maintained With a $155.00/Share by Wells Fargo
Dow Jones · 3d ago
GeneDx Holdings Raised to Overweight From Equal-Weight by Wells Fargo
Dow Jones · 3d ago
Wells Fargo Upgrades GeneDx Holdings to Overweight, Maintains Price Target to $155
Benzinga · 3d ago
Cathie Wood's Ark Invest buys the dip in tech and crypto, bags AMD, GOOG, CRCL, and HOOD
Seeking Alpha · 3d ago
GENEDX HOLDINGS CORP. <WGS.O>: WELLS FARGO RAISES TO OVERWEIGHT FROM EQUAL WEIGHT
Reuters · 3d ago
More
About WGS
GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.

Webull offers GeneDx Holdings Corp stock information, including NASDAQ: WGS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WGS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading WGS stock methods without spending real money on the virtual paper trading platform.